About Half of Older ICU Survivors Have Functional Recovery

Share this content:
About Half of Older ICU Survivors Have Functional Recovery
About Half of Older ICU Survivors Have Functional Recovery

THURSDAY, Aug. 11, 2016 (HealthDay News) -- About half of older intensive care unit (ICU) survivors have functional recovery within six months, with higher body mass index and functional self-efficacy associated with recovery, according to a study published in the Aug. 1 issue of the American Journal of Respiratory and Critical Care Medicine.

Lauren E. Ferrante, M.D., from the Yale School of Medicine in New Haven, Conn., and colleagues examined the incidence and time to recovery of premorbid function within six months of a critical illness in a sample of 218 ICU admissions from 186 ICU survivors. They examined the correlations with recovery for 21 potential predictors.

The researchers found that 52.3 percent of the 218 admissions had functional recovery. Higher body mass index and greater functional self-efficacy, a measure of confidence in performing various activities, correlated with recovery in multivariable analysis (hazard ratios, 1.07 and 1.05, respectively). Pre-ICU impairment in hearing and vision correlated with a lack of recovery (hazard ratios, 0.38 and 0.59, respectively).

"Among older adults who survived an ICU admission with increased disability, pre-ICU hearing and vision impairment were strongly associated with poor functional recovery within six months, whereas higher body mass index and functional self-efficacy were associated with recovery," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »